Skip to main content
. 2017 Jun 28;99(6):479–484. doi: 10.1308/rcsann.2017.0072

Table 1.

The various prognostic scoring systems and risk stratification used in the study

Scoring system Formula Risk stratification
TNM T0 = no tumour detected
T1 = intrathyroidal tumour <1cm
T2 = intrathyroidal tumour 1–4cm
T3 = intrathyroidal tumour >4cm
T4 = locally invasive tumour of any size
T4a = moderately advanced
T4b = very advanced
N0 = no regional lymph node involvement
N1 = regional lymph node metastasis
N1a = metastasis to level VI nodes
N1b = metastasis to all other cervical nodes
M0 = no distant metastasis
M1 = distant metastasis
5-year survival
 Stage I <45 years: any T, any N, M0 = 100%
 Stage I ≥45 years: T1, N0, M0 = 100%
 Stage II <45 years: any T, any N, M1 = 100%
 Stage II >45 years: T2, N0, M0 = 100%
 Stage III: T3, N0, M0 or T1–3, N1a, M0 = 71%
 Stage IVA: T1–3, N1b, M0 or T4a, any N, M0 = 50%
 Stage IVB: T4b, any N, M0 = 50%
 Stage IVC: any T, any N, M1 = 50%
AGES 0.05 x age in years (if age is ≥40 years) or +0 (if age is <40 years)
+1 if tumour is grade 2
+3 if tumour is grade 3 or 4
+3 if distant metastases
+0.2 x tumour size in cm
20-year survival
 ≤3.99 = 99%
 4–4.99 = 80%
 5–5.99 = 67%
 ≥6 = 13%
MACIS 3.1 (if age <40 years) or 0.08 x age in years (if age ≥40 years)
+0.3 x tumour size in cm
+1 if incompletely resected
+1 if locally invasive
+3 if distant metastases
20-year survival
 <6 = 99%
 6–6.99 = 89%
 7–7.99 = 56%
 ≥8 = 24%
AMES Low risk: Men ≤40 years or women ≤50 years with no metastases, or older patients with intrathyroidal lesions, minor capsular invasion, tumour size <5cm and no distant metastases
High risk: All patients with distant metastases, extrathyroidal lesions or major capsular invasion, or tumour size ≥5cm in older patients
20-year survival
 Low risk = 99%
 High risk = 61%
EORTC +12 if male, +10 if follicular lesion is poorly differentiated, +10 if ≥T3, +15 if there is one distant metastasis, +15 for each additional metastasis 5-year survival
 <50 = 95%
 50–65 = 80%
 66–83 = 51%
 84–108 = 33%
 >108 = 5%

AGES = Age, Grade, Extent, Size; AMES = Age, Metastases, Extent, Sex; EORTC = European Organisation for Research and Treatment of Cancer; TNM = Tumour, Nodes, Metastases; MACIS = Metastases, Age, Completeness of resection, Invasion, Size